title: 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
authors.forename: Richard L
authors.initials: RL
authors.lastname: Page
authors.forename: José A
authors.initials: JA
authors.lastname: Joglar
authors.forename: Mary A
authors.initials: MA
authors.lastname: Caldwell
authors.affiliation: Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry and other entities may apply; see Appendix 1 for recusal information.HRS Representative. ACC/AHA Representative. ACC/AHA Task Force on Performance Measures Liaison. ACC/AHA Task Force on Clinical Practice Guidelines Liaison. Former Task Force member; current member during this writing effort.
authors.forename: Hugh
authors.initials: H
authors.lastname: Calkins
authors.affiliation: Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry and other entities may apply; see Appendix 1 for recusal information.HRS Representative. ACC/AHA Representative. ACC/AHA Task Force on Performance Measures Liaison. ACC/AHA Task Force on Clinical Practice Guidelines Liaison. Former Task Force member; current member during this writing effort.
authors.forename: Jamie B
authors.initials: JB
authors.lastname: Conti
authors.affiliation: Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry and other entities may apply; see Appendix 1 for recusal information.HRS Representative. ACC/AHA Representative. ACC/AHA Task Force on Performance Measures Liaison. ACC/AHA Task Force on Clinical Practice Guidelines Liaison. Former Task Force member; current member during this writing effort.
authors.forename: Barbara J
authors.initials: BJ
authors.lastname: Deal
authors.affiliation: Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry and other entities may apply; see Appendix 1 for recusal information.HRS Representative. ACC/AHA Representative. ACC/AHA Task Force on Performance Measures Liaison. ACC/AHA Task Force on Clinical Practice Guidelines Liaison. Former Task Force member; current member during this writing effort.
authors.forename: N A Mark
authors.initials: NA
authors.lastname: Estes
authors.affiliation: Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry and other entities may apply; see Appendix 1 for recusal information.HRS Representative. ACC/AHA Representative. ACC/AHA Task Force on Performance Measures Liaison. ACC/AHA Task Force on Clinical Practice Guidelines Liaison. Former Task Force member; current member during this writing effort.
authors.forename: Michael E
authors.initials: ME
authors.lastname: Field
authors.affiliation: Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry and other entities may apply; see Appendix 1 for recusal information.HRS Representative. ACC/AHA Representative. ACC/AHA Task Force on Performance Measures Liaison. ACC/AHA Task Force on Clinical Practice Guidelines Liaison. Former Task Force member; current member during this writing effort.
authors.forename: Zachary D
authors.initials: ZD
authors.lastname: Goldberger
authors.affiliation: Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry and other entities may apply; see Appendix 1 for recusal information.HRS Representative. ACC/AHA Representative. ACC/AHA Task Force on Performance Measures Liaison. ACC/AHA Task Force on Clinical Practice Guidelines Liaison. Former Task Force member; current member during this writing effort.
authors.forename: Stephen C
authors.initials: SC
authors.lastname: Hammill
authors.affiliation: Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry and other entities may apply; see Appendix 1 for recusal information.HRS Representative. ACC/AHA Representative. ACC/AHA Task Force on Performance Measures Liaison. ACC/AHA Task Force on Clinical Practice Guidelines Liaison. Former Task Force member; current member during this writing effort.
authors.forename: Julia H
authors.initials: JH
authors.lastname: Indik
authors.affiliation: Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry and other entities may apply; see Appendix 1 for recusal information.HRS Representative. ACC/AHA Representative. ACC/AHA Task Force on Performance Measures Liaison. ACC/AHA Task Force on Clinical Practice Guidelines Liaison. Former Task Force member; current member during this writing effort.
authors.forename: Bruce D
authors.initials: BD
authors.lastname: Lindsay
authors.affiliation: Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry and other entities may apply; see Appendix 1 for recusal information.HRS Representative. ACC/AHA Representative. ACC/AHA Task Force on Performance Measures Liaison. ACC/AHA Task Force on Clinical Practice Guidelines Liaison. Former Task Force member; current member during this writing effort.
authors.forename: Brian
authors.initials: B
authors.lastname: Olshansky
authors.affiliation: Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry and other entities may apply; see Appendix 1 for recusal information.HRS Representative. ACC/AHA Representative. ACC/AHA Task Force on Performance Measures Liaison. ACC/AHA Task Force on Clinical Practice Guidelines Liaison. Former Task Force member; current member during this writing effort.
authors.forename: Andrea M
authors.initials: AM
authors.lastname: Russo
authors.affiliation: Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry and other entities may apply; see Appendix 1 for recusal information.HRS Representative. ACC/AHA Representative. ACC/AHA Task Force on Performance Measures Liaison. ACC/AHA Task Force on Clinical Practice Guidelines Liaison. Former Task Force member; current member during this writing effort.
authors.forename: Win-Kuang
authors.initials: WK
authors.lastname: Shen
authors.affiliation: Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry and other entities may apply; see Appendix 1 for recusal information.HRS Representative. ACC/AHA Representative. ACC/AHA Task Force on Performance Measures Liaison. ACC/AHA Task Force on Clinical Practice Guidelines Liaison. Former Task Force member; current member during this writing effort.
authors.forename: Cynthia M
authors.initials: CM
authors.lastname: Tracy
authors.forename: Sana M
authors.initials: SM
authors.lastname: Al-Khatib
mesh_terms: D000293:Adolescent; D000328:Adult; D002317:Cardiovascular Agents / Q000191:economics / Q000627:therapeutic use; D017115:Catheter Ablation / Q000191:economics; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D003362:Cost-Benefit Analysis; D003657:Decision Making; D003935:Diagnostic Techniques, Cardiovascular; D019468:Disease Management; D004562:Electrocardiography; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D008297:Male; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000628:therapy; D011788:Quality of Life; D013617:Tachycardia, Supraventricular / Q000145:classification / Q000175:diagnosis / Q000191:economics / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy*; D055815:Young Adult
chemical_list: D002317:Cardiovascular Agents
keywords: AHA Scientific Statements; Valsalva maneuver; Wolff-Parkinson-White syndrome; accessory atrioventricular bundle; anti-arrhythmia agents; atrial flutter; catheter ablation; death, sudden; electric countershock; electrophysiologic techniques, cardiac; heart defects, congenital; sinus tachycardia; tachycardia, atrioventricular nodal reentry; tachycardia, ectopic atrial; tachycardia, ectopic junctional; tachycardia, reciprocating; tachycardia, supraventricular